Skip to search formSkip to main contentSkip to account menu

ABT 255

Known as: ABT-255 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
[Prospects for development of new antituberculous drugs].
  • H. Tomioka
  • Kekkaku : [Tuberculosis]
  • 2002
  • Corpus ID: 35766511
Tuberculosis (TB) is a growing international health concern, since it is the leading infectious cause of death in the world today… 
Review
2000
Review
2000
Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
In this article, I have thoroughly reviewed the status of development of new antimycobacterial drugs, in particular, rifamycin… 
1998
1998
In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosisStrains
ABSTRACT Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)